中国医学科学院肿瘤医院博士生王晓雷在唐平章、赵清正教授的指导下，利用Ｅ１Ａ基因研制出一种新型生物制剂——Ｐ２ＬＭ，并从分子水平、细胞水平到动物水平进行了系统研究。动物实验结果表明，该制剂能抑制多种肿瘤的生长。对人头颈鳞癌及头颈淋巴结转移癌细胞的生长有明显 Under the guidance of Professor Tang Pingzhang and Professor Zhao Qingzheng, a new biological preparation of P2LM was developed by E1A gene from molecular level, cellular level and animal level. Animal experiments show that the preparation can inhibit the growth of a variety of tumors. On the head and neck squamous cell carcinoma and head and neck lymph node metastasis of cancer cells were significantly